
CAS 851095-32-4: STX-0119
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | STX-0119 REF: TM-T60160CAS: 851095-32-4 | 99.42% | To inquire | Thu 17 Apr 25 |
![]() | N-[5-(2-Furanyl)-1,3,4-oxadiazol-2-yl]-2-phenyl-4-quinolinecarboxamide REF: TR-F863670CAS: 851095-32-4 | - - - | 1,151.00 € | Tue 27 May 25 |
![]() | N-[5-(Furan-2-yl)-1,3,4-oxadiazol-2-yl]-2-phenylquinoline-4-carboxamide REF: 3D-BJB09532CAS: 851095-32-4 | Min. 95% | - - - | Discontinued product |

STX-0119
CAS:851095-32-4
STX-0119 is a selective, orally active STAT3 dimerization inhibitor. STX-0119 inhibits STAT3 transcription with an …
Formula:
C22H14N4O3
Purity:
99.42%
Color and Shape:
Liquid
Molecular weight:
382.37
Ref: TM-T60160
5mg | 64.00 € | ||
10mg | 92.00 € | ||
25mg | 177.00 € | ||
50mg | 283.00 € | ||
100mg | 425.00 € | ||
500mg | To inquire | ||
1mL*10mM (DMSO) | 64.00 € |
Estimated delivery in United States, on Thursday 17 Apr 2025

N-[5-(2-Furanyl)-1,3,4-oxadiazol-2-yl]-2-phenyl-4-quinolinecarboxamide
Controlled ProductCAS:851095-32-4
Formula:
C22H14N4O3
Color and Shape:
Neat
Molecular weight:
382.37
Ref: TR-F863670
100mg | 1,151.00 € |
Estimated delivery in United States, on Tuesday 27 May 2025

N-[5-(Furan-2-yl)-1,3,4-oxadiazol-2-yl]-2-phenylquinoline-4-carboxamide
CAS:851095-32-4
Please enquire for more information about N-[5-(Furan-2-yl)-1,3,4-oxadiazol-2-yl]-2-phenylquinoline-4-carboxamide including the price, delivery time and more detailed …
Formula:
C22H14N4O3
Purity:
Min. 95%
Molecular weight:
382.4 g/mol
Ref: 3D-BJB09532
Undefined size | Discontinued | Request information | |
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information |